Afya (AFYA) Q2 2025: Undergraduate Revenue Climbs 16% as Margin Efficiency Sets New High
Afya extended its margin leadership in Q2, driven by operational leverage and robust undergraduate growth. Strategic cost centralization and disciplined capital allocation fueled record profitability, while the company maintained a conservative outlook amid regulatory and competitive shifts. Buybacks and M&A selectivity signal confidence, but sector headwinds and tax uncertainties demand vigilance into year-end.
Summary
- Margin Expansion Outpaces Sector: Centralized cost structure and mature campuses pushed EBITDA margin to all-time high.
- Undergraduate Engine Drives Predictability: Medicine student base and ticket growth underpin resilient revenue mix.
- Capital Allocation Tightens: Buyback launch and selective M&A reflect confidence but highlight liquidity and pricing discipline needs.
Business Overview
Afya is a leading provider of medical education and digital health solutions in Brazil. The company generates revenue through three main segments: Undergraduate Programs (primarily medicine degrees), Continuing Education (specialization and residency prep), and Medical Practice Solutions (B2B and B2C digital services for physicians). The core business model is rooted in recurring tuition from a large student base and digital ecosystem monetization, with most revenue tied to the health and medical sectors.
Performance Analysis
Afya delivered double-digit top-line growth in Q2, with undergraduate revenue up over 16% year-over-year, representing 86% of segment revenue. The undergraduate segment’s performance was powered by a 14% increase in medical student enrollment, as well as successful integration of recent acquisitions and the ramp-up of new campuses. Net average ticket for medical courses rose 3.2%, reflecting both price discipline and a stable demand environment, despite a slight drag from government tuition discount programs.
Continuing education revenue grew 8%, supported by a 12% increase in graduate journey students, though residency prep volumes dropped 29% due to sector-wide intake softness. Medical practice solutions grew 9%, with B2B business-to-physician revenue up 12% but B2C down 8%, showing a mixed digital monetization profile. Adjusted EBITDA margin reached a record 48.1% for the first half, up 220 basis points, with SG&A efficiencies and shared service centralization as major drivers. Cash flow conversion remained robust, and net debt fell even after dividend payouts and acquisitions.
- Operational Leverage Realized: Matured campuses and centralized shared services reduced cost per student, expanding margins.
- Undergrad Mix Shields Volatility: 94% of revenue from health-related courses, limiting exposure to weaker education categories.
- Digital Ecosystem Engagement High: 302,000 active users reflect broad reach, though monthly active users declined 9% YoY in medical practice solutions.
Overall, Afya’s business mix and operational discipline delivered record profitability, even as pockets of the portfolio (residency prep, B2C digital) showed cyclical softness. The company’s ability to pass through moderate tuition increases and maintain full occupancy in medical seats points to continued demand resilience.
Executive Commentary
"This performance highlights the high predictability of our business model and the successful execution of our strategy, which consistently combines robust growth, increased profitability, and solid cash generation."
Virgilio Gibon, Chief Executive Officer
"It's worth to mention here that, well, this first half, it's an all-time high first half EBITDA margin since we began public trading in 2019. So we are talking about efficiency. So that's the beautiful, all the models that we designed in the past, and now we have the full maturation of most of our campuses, our operation, and also, as Blanco mentioned, also capturing value and leverage from continued education and digital services."
Virgilio Gibon, Chief Executive Officer
Strategic Positioning
1. Centralized Cost Structure and Operational Leverage
Afya’s shared service center and SG&A centralization initiatives have driven meaningful margin expansion. By consolidating administrative and operational functions across segments, the company has unlocked scale benefits, reducing per-student costs and boosting efficiency. This approach is now fully embedded, with ongoing synergy capture expected as new campuses and acquisitions mature.
2. Undergraduate Medicine as Growth Anchor
The undergraduate medicine program remains the strategic core, providing predictable, high-margin revenue. The company’s ability to maintain 100% seat occupancy and grow the student base by 14% demonstrates strong brand positioning and demand insulation. Medicine now accounts for 86% of undergraduate revenue and 94% of all health-related sales, reinforcing Afya’s sector leadership.
3. Selective Capital Deployment: Buybacks and M&A
Afya’s new buyback program authorizing up to 4 million Class A shares by 2026 signals confidence in long-term value creation. Management emphasized a balanced approach between dividends and buybacks, seeking to optimize shareholder returns and EPS growth. In M&A, the company remains disciplined, prioritizing reputation, location, and price in new deals, especially as sector valuations compress and distressed assets emerge.
4. Navigating Regulatory and Tax Headwinds
Implementation of OECD Pillar 2 minimum tax rules is beginning to impact effective rates, though deferred tax assets have provided short-term relief. Afya is actively pursuing legal and administrative channels to mitigate the impact, particularly as the ProUni program’s exclusion from qualified credits could raise structural tax costs. Management expects effective tax rates to converge toward 15% over time.
5. Digital Ecosystem Monetization and Engagement
With over 300,000 active users in its digital ecosystem, Afya is well positioned to deepen physician engagement and cross-sell services. However, monthly active users in medical practice solutions declined 9% YoY, highlighting the need for renewed focus on digital product relevance and retention, especially in B2C channels.
Key Considerations
Afya’s quarter underscores the power of a focused medical education model with operational leverage, but also surfaces emerging sector and regulatory risks that warrant close monitoring.
Key Considerations:
- SG&A Efficiency as Margin Driver: Centralization and shared services have proven highly effective, but further gains may be incremental as the model matures.
- Medical Seat Expansion at Capacity: Maintaining full occupancy amid increased competition and new seat approvals will be crucial for sustaining pricing power and predictability.
- Buyback Program’s Impact on Liquidity: The 4 million share buyback is sizable relative to free float, potentially affecting stock liquidity and trading dynamics.
- Tax Regime Uncertainty: Ongoing legal and legislative challenges around Pillar 2 and ProUni credits could materially affect future earnings quality.
- Digital Engagement Dip: Declining monthly actives in medical practice solutions suggest a need to reinvigorate digital offerings and user stickiness.
Risks
Key risks include increased competition for medical seats as new approvals dilute candidate ratios, persistent regulatory and tax uncertainty—especially around OECD Pillar 2 and ProUni—and digital engagement weakness in B2C channels. Buyback execution may pressure liquidity, and residency prep softness could persist if sector intake does not rebound. Management’s conservative guidance reflects these uncertainties, particularly around seasonality in continuing education and evolving regulatory frameworks.
Forward Outlook
For Q3 2025, Afya guided to:
- Continued margin discipline with operational leverage from maturing campuses and centralized SG&A
- Stable undergraduate medicine intake and full seat occupancy
For full-year 2025, management maintained guidance:
- Revenue and EBITDA at previously communicated ranges, citing confidence in undergraduate intake but caution on continuing education seasonality
Management highlighted several factors that could shape H2:
- “We prefer to keep on the conservative side here, mostly because we have like a seasonality on continuing education.”
- Effective tax rate expected to converge toward 15% as deferred asset benefits wane
Takeaways
Afya’s Q2 performance validates its operational model and margin strategy, but the path forward will require careful management of sector, regulatory, and digital transformation risks.
- Margin Leadership Confirmed: Record EBITDA margin reflects the full effect of cost centralization and campus maturation, setting a new benchmark for sector peers.
- Portfolio Mix as Buffer: Heavy weighting toward undergraduate medicine insulates revenue and margin, but exposes the company to regulatory and competitive seat risk.
- Watch Digital and Tax Trends: Investors should monitor digital user engagement and the outcome of tax challenges, as both could materially alter future earnings power.
Conclusion
Afya’s Q2 2025 results reinforce its position as Brazil’s margin leader in medical education, powered by operational discipline and a resilient undergraduate franchise. While capital allocation moves and margin gains are clear positives, regulatory and engagement headwinds warrant close scrutiny as the company navigates the balance of 2025.
Industry Read-Through
Afya’s results highlight the advantage of scale and operational centralization in Brazil’s medical education sector, with mature campuses and shared services driving margin outperformance. The sector faces intensifying competition for medical seats as regulatory approvals rise, potentially pressuring candidate quality and pricing across the industry. Tax regime shifts and the treatment of government programs like ProUni are set to reshape earnings quality for all education providers, not just Afya. Finally, the mixed performance in digital health solutions signals that ecosystem engagement is not guaranteed—peer companies must invest in product relevance and retention to avoid user churn.